For: | Günaltay S, Nyhlin N, Kumawat AK, Tysk C, Bohr J, Hultgren O, Hörnquist EH. Differential expression of interleukin-1/Toll-like receptor signaling regulators in microscopic and ulcerative colitis. World J Gastroenterol 2014; 20(34): 12249-12259 [PMID: 25232259 DOI: 10.3748/wjg.v20.i34.12249] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12249.htm |
Number | Citing Articles |
1 |
Johan Bohr, Fernando Fernández‐Bañares, Ole K. Bonderup. Evidence‐based Gastroenterology and Hepatology 4e. 2019; : 196 doi: 10.1002/9781119211419.ch13
|
2 |
Tian Hua Ren, Min Min Lv, Xiao Meng An, Wai Keung Leung, Wai‐Kay Seto. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down‐regulating the nuclear factor‐kappa B signaling. Journal of Digestive Diseases 2020; 21(1): 38 doi: 10.1111/1751-2980.12831
|
3 |
Stephan Miehlke, Bas Verhaegh, Gian Eugenio Tontini, Ahmed Madisch, Cord Langner, Andreas Münch. Microscopic colitis: pathophysiology and clinical management. The Lancet Gastroenterology & Hepatology 2019; 4(4): 305 doi: 10.1016/S2468-1253(19)30048-2
|
4 |
Feng Zhu, Huarong Li, Yujin Liu, Chen Tan, Xingxing Liu, Heng Fan, Hui Wu, Yalan Dong, Ting Yu, Si Chu, Hongxia He, Xiwen Zhu. miR-155 antagomir protect against DSS-induced colitis in mice through regulating Th17/Treg cell balance by Jarid2/Wnt/β-catenin. Biomedicine & Pharmacotherapy 2020; 126: 109909 doi: 10.1016/j.biopha.2020.109909
|
5 |
Anna Carrasco, Eva Tristán, Fernando Fernández‐Bañares, Albert Martín‐Cardona, Montserrat Aceituno, Yamile Zabana, Lourdes Fluvià, José María Hernández, Violeta Lorén, Josep Manyé, Antonio Salas, Xavier Andújar, Carme Loras, Maria Esteve. Mucosal Interleukin‐10 depletion in steroid‐refractory Crohn's disease patients. Immunity, Inflammation and Disease 2022; 10(10) doi: 10.1002/iid3.710
|
6 |
Ying Li, Mengyao Tang, Feng Jun Zhang, Yihan Huang, Jing Zhang, Junqi Li, Yunpeng Wang, Jinguang Yang, Shu Zhu. Screening of ulcerative colitis biomarkers and potential pathways based on weighted gene co-expression network, machine learning and ceRNA hypothesis. Hereditas 2022; 159(1) doi: 10.1186/s41065-022-00259-4
|
7 |
Laura Francesca Pisani, Gian Eugenio Tontini, Maurizio Vecchi, Luca Pastorelli. Microscopic Colitis. Inflammatory Bowel Diseases 2016; 22(2): 450 doi: 10.1097/MIB.0000000000000628
|
8 |
Daniel E. Rothschild, Yao Zhang, Na Diao, Christina K. Lee, Keqiang Chen, Clayton C. Caswell, Daniel J. Slade, Richard F. Helm, Tanya LeRoith, Liwu Li, Irving C. Allen. Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M. EBioMedicine 2017; 15: 36 doi: 10.1016/j.ebiom.2016.11.039
|
9 |
Sezin Günaltay, Mohammed Ghiboub, Olof Hultgren, Elisabeth Hultgren Hörnquist. Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells. Digestive Diseases and Sciences 2017; 62(5): 1204 doi: 10.1007/s10620-016-4422-9
|
10 |
Junhui Bai, Yukun Li, Meixiang Li, Sijie Tan, Daichao Wu. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases. Current Drug Targets 2020; 21(9): 855 doi: 10.2174/1389450121666200429114926
|
11 |
Huimin Yan, Xinyu Zhang, Yi Xu. Aberrant expression of miR-21 in patients with inflammatory bowel disease. Medicine 2020; 99(17): e19693 doi: 10.1097/MD.0000000000019693
|
12 |
Pingping Wang, Haidong Wang, Cuihong Li, Xiaozhen Zhang, Xia Xiu, Ping Teng, Zengfang Wang. Dysregulation of microRNA‐657 influences inflammatory response via targeting interleukin‐37 in gestational diabetes mellitus. Journal of Cellular Physiology 2019; 234(5): 7141 doi: 10.1002/jcp.27468
|
13 |
Luca Pastorelli, Theresa T. Pizarro. Interleukin-37: A Peacekeeper at the Intestinal Borders. Digestive Diseases and Sciences 2017; 62(5): 1103 doi: 10.1007/s10620-017-4523-0
|
14 |
Anna Carrasco, Maria Esteve, Antonio Salas, Elisabet Pedrosa, Mercè Rosinach, Montserrat Aceituno, Yamile Zabana, Fernando Fernández-Bañares. Immunological Differences between Lymphocytic and Collagenous Colitis. Journal of Crohn's and Colitis 2016; 10(9): 1055 doi: 10.1093/ecco-jcc/jjw058
|
15 |
Shengwei Liu, Cui He, Yuan Liao, Hailin Liu, Wanli Mao, Zhengze Shen, Francesca Mancianti. Enhancing and Complementary Mechanisms of Synergistic Action of Acori Tatarinowii Rhizoma and Codonopsis Radix for Alzheimer’s Disease Based on Systems Pharmacology. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/6317230
|
16 |
Johanna K. Larsson, Konstantinos J. Dabos, Peter Höglund, Johan Bohr, Andreas Münch, Andry Giannakou, Artur Nemeth, Gabriele Wurm-Johansson, Ervin Toth, John N. Plevris, Paul Fineron, Anastasios Koulaouzidis, Klas Sjöberg. Cancer Risk in Collagenous Colitis. Journal of Clinical Medicine 2019; 8(11): 1942 doi: 10.3390/jcm8111942
|
17 |
Lijuan Wang, Yanchun Quan, Yongfang Yue, Xueyuan Heng, Fengyuan Che. Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.7982
|
18 |
Wang-Dong Xu, Yi Zhao, Yi Liu. Insights into IL-37, the role in autoimmune diseases. Autoimmunity Reviews 2015; 14(12): 1170 doi: 10.1016/j.autrev.2015.08.006
|
19 |
Sezin Günaltay, Dirk Repsilber, Gisela Helenius, Nils Nyhlin, Johan Bohr, Olof Hultgren, Elisabeth Hultgren Hörnquist. Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis. Inflammatory Bowel Diseases 2017; 23(6): 932 doi: 10.1097/MIB.0000000000001127
|
20 |
Emese Mihaly, Árpád Patai, Zsolt Tulassay. Controversials of Microscopic Colitis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.717438
|
21 |
Yan Li, Nuo Chen, Yaxin Guo, Lining Zhang. The stress and the alarmin-like cytokine interleukin-37 mediated extracellular and intracellular signal pathways. Seminars in Immunology 2025; 78: 101952 doi: 10.1016/j.smim.2025.101952
|
22 |
Lin-Chong Su, Wang-Dong Xu, An-Fang Huang. IRAK family in inflammatory autoimmune diseases. Autoimmunity Reviews 2020; 19(3): 102461 doi: 10.1016/j.autrev.2020.102461
|
23 |
Andreas Münch, Celia Escudero‐Hernández. Dissecting Microscopic Colitis Immunopathophysiology: Insights From Basic Research. United European Gastroenterology Journal 2025; doi: 10.1002/ueg2.70024
|
24 |
Craig P. McEntee, Conor M. Finlay, Ed C. Lavelle. Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01266
|
25 |
Christina Begka, Dominique Velin, Michel H. Maillard. Preventing Overheating. Inflammatory Bowel Diseases 2016; 22(7): 1723 doi: 10.1097/MIB.0000000000000838
|
26 |
Charles A. Dinarello, Claudia Nold‐Petry, Marcel Nold, Mayumi Fujita, Suzhao Li, Soohyun Kim, Philip Bufler. Suppression of innate inflammation and immunity by interleukin‐37. European Journal of Immunology 2016; 46(5): 1067 doi: 10.1002/eji.201545828
|
27 |
Dániel Szűcs, Nóra Judit Béres, Réka Rokonay, Kriszta Boros, Katalin Borka, Zoltán Kiss, András Arató, Attila J Szabó, Ádám Vannay, Erna Sziksz, Csaba Bereczki, Gábor Veres. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World Journal of Gastroenterology 2016; 22(26): 6027-6035 doi: 10.3748/wjg.v22.i26.6027
|
28 |
Elena Mosso, Valentina Boano, Mario Grassini, Edda Battaglia, Rinaldo Pellicano. Microscopic colitis: a narrative review with clinical approach. Minerva Gastroenterologica e Dietologica 2019; 65(1) doi: 10.23736/S1121-421X.18.02539-4
|
29 |
Wuwen Feng, Hui Ao, Shijun Yue, Cheng Peng. Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34509-1
|
30 |
Yuning Jia, Shoaib Anwaar, Linyun Li, Zhihua Yin, Zhizhon Ye, Zhong Huang. A new target for the treatment of inflammatory bowel disease: Interleukin-37. International Immunopharmacology 2020; 83: 106391 doi: 10.1016/j.intimp.2020.106391
|
31 |
Jiyu Tong, Xuefei Wang, Yongbo Liu, Xingxing Ren, Anmin Wang, Zonggui Chen, Jiameng Yao, Kaiqiong Mao, Tingting Liu, Fei-Long Meng, Wen Pan, Qiang Zou, Jun Liu, Yu Zhou, Qiang Xia, Richard A. Flavell, Shu Zhu, Hua-Bing Li.
Pooled CRISPR screening identifies m
6
A as a positive regulator of macrophage activation
. Science Advances 2021; 7(18) doi: 10.1126/sciadv.abd4742
|